August, 2007


Copyright 2007 Center for Phlebotomy Education, Inc.
 All rights reserved. View our copyright policy.

 

Fibrin: Friend of Foe?

When you accidentally cut yourself or are bleeding from an injury, fibrin is your friend. It stops the bleeding and eventually forms a stable mat of tissue that seals the wound from infection while the damaged tissue regenerates. But when you pull red-top tubes from the centrifuge, the same fibrin is your foe. More accurately, it’s your patient’s foe. That’s because fibrin formation in the tube to be tested may lead to instrumentation problems and/or inaccurate results. To fight these threats of fibrin, let’s look at how it works against the patient in the clinical laboratory.

It’s not just clot tubes that are susceptible to fibrin formation. Fibrin can develop in all tubes because of one or more of the following conditions:

  • Overfilling
  • Premature centrifugation
  • Improper mixing
  • Incomplete clotting

Overfilling collection tubes

Anticoagulant tubes are calibrated with the perfect amount of additive to maintain the proper blood:anticoagulant ratio when the tube is filled to +10% of its stated capacity. Overfilling tubes beyond 10% increases this ratio to a level that can lead to incomplete anticoagulation, and the formation of fibrin strands or clots. Make sure you fill all tubes to their stated volumes. Specimens that are overfilled should be discarded and recollected.

Premature centrifugation

Premature centrifugation is the most common cause of post-centrifugation fibrin in serum samples. When prematurely centrifuged, clotting can continue long after centrifugation. Should such specimens be inadvertently tested, the continually forming fibrin can obstruct and/or disable sensitive laboratory testing instruments. Post-centrifugation fibrin formation can lead to instrument down time, which delays testing, potentially affecting patient care adversely. Worse, fibrin strands that don’t impede instrumentation can lead to erroneous results that go undetected and precipitate patient mismanagement.

Tubes with clot activators should be allowed to clot for 30 minutes. Contrary to popular belief, clot activators don’t accelerate clotting, they facilitate more complete clotting. Their real benefit is that they generate a cleaner, more fibrin-free serum sample, one less likely to cause instrumentation problems or threaten result accuracy. Although clot activators cause clot tubes to gel up faster, manufacturers will tell you such tubes still require 20-30 minutes for clotting to complete. Allowing all tubes without anticoagulants to clot in an upright position for 30 minutes prior to centrifugation is the best way to prevent fibrin from threatening instrumentation and test accuracy.

Not only does premature centrifugation incorporate delays in testing due to recentrifugation and increased handling, the physical removal of fibrin can potentially expose the processor to bloodborne pathogens. When necessary, fibrin may be removed with wooden applicators and discarded into a biohazardous waste receptacle. However, whenever stoppers are removed, proper personal protection equipment must be used including face protection, gloves, and a closed lab coat.

Incomplete clotting

Delayed or prolonged coagulation can result in fibrin formation well beyond the 30-minute recommendation for pre-centrifugation clotting. Blood from patients on anticoagulant therapy or with coagulopathies can continue to clot long after centrifugation, even throughout serum storage. As in premature centrifugation, delayed or prolonged clotting may continue into the analytical phase and cause the same instrumentation malfunctions and erroneous results. Such specimens must be closely monitored throughout the preanalytical and analytical phases. If the test methodology permits, plasma samples may be considered as an alternative in order to eliminate the potential problems post-centrifugation fibrin formation can cause.

Improper mixing with additives

Failure to properly and timely mix tubes with anticoagulants can lead to fibrin formation as well. When additives are not well mixed with the specimen, fibrin can precipitate before, during and after centrifugation. Even plasma tubes must be inspected for fibrin formation prior to testing. To prevent fibrin formation due to improper mixing, all tubes should be inverted immediately upon filling according to the manufacturer’s recommended number of inversions.

Center Announces Free Products/Services

Starting this month, visitors to the Center’s homepage will find a link to a free article posted monthly or bi-monthly, depending on how well it is received. We’ll start with some interesting interviews we’ve had through the years, too intriguing to be buried in our archives forever, then see how it goes. They’ll be yours to read, share, learn from, print, and file for future reference. And that’s just the beginning. Every package we ship out will now come with a free, colorful bookmark listing the proper order of draw, something we consider to be phlebotomy’s best-kept secret. Not that the order of draw is a secret, but the proper order as recommended by CLSI is greatly misrepresented on the Internet and in some publications.

Also, be on the lookout for an online community our web site will be hosting. Healthcare professionals around the world can gather; discuss technical concerns; the issues of the day pertaining to the field; or share their ideas, successes, and frustrations. It’s still a month or so away, but it’s in the pipeline and it will be free.

Center Makes Free Shipping Permanent

Due to an overwhelmingly positive response to its free shipping offer for July, the Center for Phlebotomy Education is making it permanent! Shipping charges will be automatically waived on all orders over $50. All purchases qualify including online orders, purchase orders, phone orders, or orders received by mail. For a catalog of all phlebotomy education products, visit the Center for Phlebotomy Education's catalog at www.phlebotomy.com/Products.html.

Feel free to forward this newsletter to a friend!

If this issue was forwarded to you from a friend, subscribe here to receive your own copy each month so that you never miss a single issue of the only free monthly newsletter devoted exclusively to blood specimen collection on the planet!

This Month in Phlebotomy Today

Hereís what subscribers to Phlebotomy Today, the Center for Phlebotomy Educationís paid-subscription newsletter currently in its 8th year of publication, are reading about this month:

  • Feature Article: Taking the Initiative with Phlebotomy
  • Ask the Safety Lady: OSHA consultant addresses these burning questions:
    • My supervisor said I can’t wear any jewelry pasted to my acrylic nails.  Why?
    • Our phlebotomists spend time entering patient demographic information into the computer in our patient service centers.  Some have complained about eyestrain.  What can be done?
  • Phlebotomy in the News: a round-up of articles on phlebotomy and phlebotomists who made Internet headlines in July including these stories:
    • Phlebotomists Sticking It to Drunk Drivers
    • Pediatric Phlebotomy Discontinued at UK Clinic
    • Ireland Hospitals Tackling Wristband Errors
    • Phlebotomist Fired for Not Labeling Specimens Properly
  • According to the Standards: Not all veins are fair game
  • Tip of the Month: Investing in Quality
  • On a Personal Note: Whatís your personal Mission Statement?
  • Activity: seek and find
  • CEU questions (institutional version only).

Buy this issue for only $9.95.

For subscription rates and to subscribe to Phlebotomy Today, visit www.phlebotomy.com/PhlebotomyToday.html. The current monthís issue will be emailed to you immediately upon subscribing.

Feel free to forward this newsletter to a friend!

If this issue was forwarded to you from a friend, subscribe here to receive your own copy each month so that you never miss a single issue of the only free monthly newsletter devoted exclusively to blood specimen collection on the planet!

 

Featured FAQ: Discard volumes

Question:Can you give a "nurse friendly" definition of line deadspace and wouldn't saying "six times the deadspace" be more accurate than just saying "5 mL"? Next, what would you consider the lesser of 2 evils for clearing deadspace - drawing a red-top with sprayed with clot activator first , or drawing an extra coag tube (if that is the first tube to be collected)? The problem is that we just switched to a low volume coag tube (2.7 mL) and that would not be enough volume to clear the deadspace.

Response:The deadspace volume is that volume of fluid that the line holds between where a syringe would be attached to withdraw the blood out and the aperture that opens up into the bloodstream. The reason we say a 5 mL discard is usually enough is that those who draw blood from vascular access devices don't always know the device's dead space volume and researching it would take too much valuable time. So as a general rule, if you discard 5 mL, that's usually at least six times the dead space volume of most vascular access devices.

You are correct that a low-volume coag tube wouldn't be enough to clear the recommended dead space volume. If you are drawing with a syringe, of course, you'd simply discard the entire syringe. But if you're drawing from a VAD with a tube holder in which the entire vacuum of the tube is applied to the opening of the lumen, you could be risking hemolysis if the VAD is smaller than, say, 18 gauge. So I would suggest doing all your draws from VADs with syringes instead of tube holders so that the pressure at the tip of the line is minimal and less likely to rupture red cells.

If you still want to apply a tube holder and draw directly into tubes, be prepared for specimen rejection. If it occurs too frequently, switch to syringes. Nevertheless, if you're drawing directly into tubes, and a coag tube is required, it's not advisable to draw into a clot activator tube as a discard tube since it is conceivable that some of the activator can carryover into the coag tube and corrupt the results. Instead, use two low-volume coag tubes or a plain non-additive tube, but not a clot activator tube. Clot activators are considered additive tubes, too. Hope this helps.

Each month, PT—STAT! will publish one of the hundreds of phlebotomy FAQs in the growing database of questions and answers available in Phlebotomy Central, the members-only section of the Center for Phlebotomy Education's web site. For information on joining Phlebotomy Central, visit www.phlebotomy.com/PhlebotomyCentral.html.

 

Specimen Collection Safety: single-use tube holders

Do you remove the needle from the syringe or tube holder before discarding?

The act of removing the needle from the drawing device is against OSHA regulations. Discarding needle/syringe or needle/tube holder assemblies as one unit minimizes the risk of exposure significantly, not only for the user, but for the downstream waste handler.

 

Featured Product: Accurate Results Begin With Me!® T-Shirt

These white tees from the Center for Phlebotomy Education proudly proclaim your dedication to accurate patient results. Identify yourself and your staff as healthcare professionals dedicated to quality results through quality specimen collection and testing. 

The distinctive starburst logo on the upper left front and a larger version of the logo exploding on the back boast the signature slogan of this popular product line “Accurate Results Begin With Me!®

Special pricing for the month of August. Use coupon code "PS8588" when placing your order for a discounted price of $9.99. (Regular price: $12.95)

100% cotton, preshrunk. Visit http://www.phlebotomy.com/AccurateResults.html to order or for more information.

Free shipping on all orders of $50 or more.

Feel free to forward this newsletter to a friend!

If this issue was forwarded to you from a friend, subscribe here to receive your own copy each month so that you never miss a single issue of the only free monthly newsletter devoted exclusively to blood specimen collection on the planet!

Newsletter Information:

PT STAT! is a free, monthly educational service provided by the Center for Phlebotomy Education, Inc., the most respected authority in phlebotomy. For a complete company profile and product list for all healthcare professionals who perform, teach or manage specimen collection procedures, visit us on the Internet at: http://www.phlebotomy.com.
Do not respond to this email. Responding to the email address from which this newsletter is sent will result in the deletion of your address from our mailing list. If you would like to send an email to the editor, send it to phlebotomy@phlebotomy.com
For images to appear, you must be logged on to the Internet.
Having a problem with reading or receiving the newsletter? Your satisfaction is important to us. Let us know by sending an email to phlebotomy@phlebotomy.com
Interested in forwarding or reprinting content from PT STAT! ? Read our copyright policy at http://www.phlebotomy.com/CopyrightPolicy.html

unsubscribe information: This email is sent to you because you have completed our online subscription form. If you would like to be removed from this list and no longer receive PT STAT!, click here to unsubscribe. You may also unsubscribe by sending a request via postal mail. Please include your name, e-mail address and a printed copy of your PT STAT issue. Send to:
Unsubscribe PT-STAT!
c/o Center for Phlebotomy Education, Inc.
P.O. Box 161
Ramsey, IN 47166

Copyright 2007, Center for Phlebotomy Education, Inc. All rights reserved. Newsletters may contain links to sites on the Internet owned and operated by third parties. The Center for Phlebotomy Education, Inc. is not responsible for the availability of, or the content located on or through, any such third-party site. Information in this document is provided "as is," without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose and freedom from infringement. The user assumes the entire risk as to the accuracy and the use of this document. We will not be liable for any damages of any kind arising from the use of this information, including, but not limited to direct, indirect, incidental, punitive, and consequential damages.